본문으로 건너뛰기
Zen Horizon
리포트
인사이트
테마
베일리 보드
Buffett Screen
검색
멤버십
리포트
인사이트
테마
베일리 보드
Buffett Screen
검색
멤버십
로그인 / 회원가입
로그인
English
中文
Español
Français
Deutsch
Português
日本語
✓
한국어
Русский
홈
›
산업별 보기
›
Medical Isotopes
산업
Medical Isotopes
Medical Isotopes 산업의 모든 리포트 — 총 1건.
44
/100
76
Buffett
Hold
Eckert & Ziegler SE: A Better Business, Not Yet a Better Price
Eckert & Ziegler is a Berlin-based radioisotope specialist supplying generators, isotope products and CDMO services whose Medical segment is becoming the group's real profit engine as radiopharmaceutical oncology increasingly relies on lutetium-177 and actinium-225. 2025 revenue reached €312.0 million with Medical gross margin climbing to 49% and net financial position ending the year at €115.2 million, but 2026 guidance implies only about 3% revenue and adjusted-EBIT growth. Rating Hold: at €14.43 the stock already sits close to its conservative fair-value zone of €11.0–11.8, leaving minimal margin of safety for new buyers.
Eckert & Ziegler SE
·
EUZ
· XETRA
·
Medical Isotopes
·
2026년 7월 15일